kabutan

ADR120S,Inc.(3750) Summary

3750
TSE Standard
ADR120S,Inc.
843
JPY
+25
(+3.06%)
Dec 5, 10:37 am JST
5.43
USD
Dec 4, 8:37 pm EST
Result
PTS
outside of trading hours
843
Dec 5, 10:37 am JST
Summary Chart Historical News Financial Result
PER
106.0
PBR
26.2
Yield
ー%
Margin Trading Ratio
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
830 JPY 5.35 USD
Previous Close Dec 4
818 JPY 5.26 USD
High Dec 5, 9:10 am
860 JPY 5.54 USD
Low Dec 5, 9:00 am
830 JPY 5.35 USD
Volume
6,300
Trading Value
5.00M JPY 0.03M USD
VWAP
844.18 JPY 5.44 USD
Minimum Trading Value
84,300 JPY 543 USD
Market Cap
7.53B JPY 0.05B USD
Number of Trades
37
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Slightly Low
1-Year Average
48
1-Year High Apr 2, 2025
1,257
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 0 1,968,400
Nov 21, 2025 0 1,968,700
Nov 14, 2025 0 1,969,600
Nov 7, 2025 0 1,973,400
Oct 31, 2025 0 1,973,000
Company Profile
Cytori Cell Research Institute, Inc. has shifted its focus to regenerative medicine, medical devices, and medical tourism as its main business areas. The company is withdrawing from real estate and hotel operations.
Sector
Information & Communication
Cytori Cell Research Institute, Inc. is developing a medical business that invests in medical assets. The company sells medical devices such as Celution centrifuges and cell therapy kits to domestic medical institutions and university hospitals. In 2022, the company obtained domestic manufacturing and sales approval for the Celution Cell Therapy Kit, a highly controlled medical device, as a treatment for male stress urinary incontinence. Cytori Cell Research Institute, Inc. is withdrawing from real estate and hotel businesses, concentrating its management resources on the medical field.